EPIX ESSA Pharma
- 6.260
- +0.060+0.97%
ESSA Pharma News
ESSA Pharma Analyst Ratings
Oppenheimer Sticks to Its Buy Rating for ESSA Pharma (EPIX)
Buy Rating Endorsed for ESSA Pharma on Robust Pipeline and Market Expansion Potential
Analysts Offer Insights on Healthcare Companies: ESSA Pharma (EPIX) and Rocket Pharmaceuticals (RCKT)
Analysts Are Bullish on Top Healthcare Stocks: Puma Biotechnology (PBYI), ESSA Pharma (EPIX)
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), AbbVie (ABBV) and ESSA Pharma (EPIX)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Phreesia (PHR), RegenXBio (RGNX) and ESSA Pharma (EPIX)
Oppenheimer Reiterates Outperform on ESSA Pharma, Maintains $17 Price Target
ESSA Pharma Analyst Ratings
Piper Sandler Sticks to Their Buy Rating for ESSA Pharma (EPIX)
Analysts Offer Insights on Healthcare Companies: ESSA Pharma (EPIX), Boston Scientific (BSX) and Gilead Sciences (GILD)
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Akero Therapeutics (AKRO) and ESSA Pharma (EPIX)
ESSA Pharma Analyst Ratings
Oppenheimer Assumes ESSA Pharma at Outperform, Announces Price Target of $17
Bloom Burton Sticks to Its Buy Rating for ESSA Pharma (EPIX)
Oppenheimer Adjusts ESSA Pharma's Price Target to $17 From $23, Maintains Outperform Rating
Bloom Burton Keeps Their Buy Rating on ESSA Pharma (EPIX)
Analysts Offer Insights on Healthcare Companies: BioMarin Pharmaceutical (BMRN), ESSA Pharma (EPIX) and Arcellx Inc (ACLX)
Watching ESSA Pharma; Piper Sandler Reiterates Overweight, $20 Price Target
ESSA Pharma (EPIX) Gets a Buy Rating from Bloom Burton
Analysis
Price Target
No Data
